logo
DPRs for Metro Phase-2 (B) approved, with JBS hub, new corridors planned for Hyderabad

DPRs for Metro Phase-2 (B) approved, with JBS hub, new corridors planned for Hyderabad

HYDERABAD: Hyderabad Airport Metro Limited (HAML) Managing Director NVS Reddy has said that the Detailed Project Reports (DPRs) for Metro Phase-2 (B) have been finalised and approved by the HAML Board on May 8 and are now under government review.
He said the DPRs include plans to develop JBS as an international hub, as directed by Chief Minister A Revanth Reddy. The proposed corridors, JBS-Medchal, JBS-Shamirpet and RGIA-Future City, span 86.1 km at a cost of Rs 19,579 crore.
The JBS-Medchal route will be a 24.5 km fully elevated corridor with 18 stations. The JBS-Shamirpet line will cover 22 km with 14 stations, 20.35 km elevated and 1.65 km underground near Hakimpet Airport.
The RGIA-Future City (Skill University) corridor will stretch 39.6 km, 1.6 km underground, 21 km elevated, and 17 km at grade, connecting RGIA to Skill University via Pedda Golconda and Raviryala ORR exits.
NVS Reddy said the DPRs were prepared in line with Central guidelines, Metro cost benchmarks in other states and Hyderabad's traffic needs. Full details will be released once the state government approves the reports and forwards them to the Centre, he added.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Aegis Vopak Terminals slips on debut
Aegis Vopak Terminals slips on debut

Business Standard

time28 minutes ago

  • Business Standard

Aegis Vopak Terminals slips on debut

Shares of Aegis Vopak Terminals were currently trading at Rs 228.95 at 10:14 IST on the BSE, representing a discount of 2.57% compared with the issue price of Rs 235. The scrip was listed at Rs 220, exhibiting a discount of 6.38% to the issue price. So far, the stock has hit a high of 235.75 and a low of 220. On the BSE, over 6.57 lakh shares of the company were traded in the counter so far. The initial public offer of Aegis Vopak Terminals was subscribed 2.09 times. The issue opened for bidding on 26 May 2025 and it closed on 28 May 2025. The price band of the IPO is fixed between Rs 223 and 235 per share. The offer comprised a fresh issue of up to 119,148,936 equity shares at the upper price band of Rs 235 and 125,560,538 equity shares at the lower price band of Rs 223, aggregating to Rs 2,800 crore. The company will use the IPO proceeds to repay borrowings worth Rs 2,015.95 crore, fund Rs 671.3 crore towards acquiring a cryogenic LPG terminal at Mangalore, and for general corporate purposes. As of 31 March 2025, total borrowings stood at Rs 2,474.17 crore. The Mangalore terminal, with a total capex of Rs 968 crore, is expected to commence operations by June 2025. The project is being developed by Sea Lord Containers, a wholly owned subsidiary of Aegis Logistics and part of the promoter group. Ahead of the IPO, Aegis Vopak Terminals on Friday, 23 May 2025, raised Rs 1,259.99 crore from anchor investors. The board allotted 53,617,021 shares at Rs 235 each to 32 anchor investors. Aegis Vopak Terminals is India's largest third-party tank storage operator for LPG and liquid products, with a total capacity of 1.5 million cubic meters for liquids and 70,800 tonnes for LPG as of 31 December 2024. The company accounts for approximately 11.5% of Indias total LPG static storage capacity and 25.5% of third-party liquid storage capacity. Aegis Vopak is a joint venture between Aegis Logistics (50.1%) and Vopak India BV (47.4%), part of Dutch-based Royal Vopak, a global leader in tank storage with 77 terminals in 23 countries. The company is expanding LPG storage capacity to 200,800 tonnes by FY26 and recently added 101,900 cubic meters of liquid storage at its JNPA terminal in Navi Mumbai. The firm reported a consolidated net profit of Rs 85.8910 crore and total income of Rs 464.18 crore for the nine months ended on 31 December 2024.

Cipla's Bengaluru facility gets one USFDA observation
Cipla's Bengaluru facility gets one USFDA observation

Business Standard

time28 minutes ago

  • Business Standard

Cipla's Bengaluru facility gets one USFDA observation

Cipla announced that the United States Food and Drug Administration (USFDA) has concluded a current Good Manufacturing Practices (cGMP) inspection at its manufacturing facility in Bommasandra, Bengaluru. According to a regulatory filing, the inspection was carried out from 26 May 2025 to 30 May 2025. At the conclusion of the inspection, the USFDA issued one observation in Form 483. The company stated that it will work closely with the USFDA and remains committed to addressing the observation comprehensively within the stipulated timeframe. In Q4 FY25, Cipla reported a 30.1% year-on-year increase in consolidated net profit to Rs 1,222 crore, while total income rose 9.2% to Rs 6,730 crore. Cipla is a global pharmaceutical company focused on agile and sustainable growth, complex generics, and deepening portfolios in our home markets of India, South Africa, North America, and key regulated and emerging markets. The scrip shed 0.19% to currently trade at Rs 1,462 on the BSE.

Schloss Bangalore (The Leela) slides on debut
Schloss Bangalore (The Leela) slides on debut

Business Standard

time28 minutes ago

  • Business Standard

Schloss Bangalore (The Leela) slides on debut

Shares of Schloss Bangalore (The Leela) were currently trading at Rs 424.90 at 10:20 IST on the BSE, representing a discount of 2.32% compared with the issue price of Rs 435. The scrip was listed at Rs 406.50, exhibiting a discount of 6.55% to the issue price. So far, the stock has hit a high of 426.90 and a low of 404.45. On the BSE, over 2.60 lakh shares of the company were traded in the counter so far. The initial public offer (IPO) of Schloss Bangalore (The Leela) was subscribed 4.50 times. The issue opened for bidding on Monday, 26 May 2025 and it closed on Wednesday, 28 May 2025. The price band of the IPO is fixed between Rs 413 and 435 per share. The IPO consisted of a fresh issue of Rs 2500 crore and an offer-for-sale (OFS) of up to Rs 1,000 crore. At the higher price band of Rs 435, the OFS comprises up to 5,74,71,264 shares by Project Ballet Bangalore Holdings (DIFC) Pvt Ltd. Out of the proceeds from the fresh issue, Rs 2300 crore will be used for repayment/prepayment/redemption, in full or in part, of certain borrowings availed of by the company and its subsidiaries, and the balance for general corporate purposes. Ahead of the IPO, Schloss Bangalore (The Leela) on Friday, 23 May 2025, raised Rs 1,574.99 crore from anchor investors. The board allotted 3,62,06,896 shares at Rs 435 each to 47 anchor investors. Schloss Bangalore (The Leela) is a luxury hospitality company operating under "The Leela" brand in India. It owns, operates, manages, and develops luxury hotels and resorts, offering premier accommodations and personalized services inspired by Indian hospitality. The owned portfolio comprises five landmark hotels across key business and leisure destinations: Bengaluru, Chennai, New Delhi, Jaipur, and Udaipur. For the financial year 2025, the company derived 56.96% of its room revenues from retail and leisure guests, 16.97% from corporate bookings, and 25.45% from group bookings, demonstrating the strength of the diversified customer base. As of March 31, 2025, Schloss Bangalore is one of Indias largest luxury hospitality companies by number of keys, with a portfolio of 13 operational hotels comprising 3,553 keys. The portfolio includes The Leela Palaces, The Leela Hotels, and The Leela Resorts. The company operates through direct ownership and hotel management agreements with third-party owners. The firm reported a consolidated net profit of Rs 47.66 crore and revenue from operations of Rs 1,300.57 crore for the financial year 2024-25.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store